Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Z Stanger

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Cancer Immunology Research|February 14, 2015
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic CarcinomaRafael Winograd, Katelyn T Byrne, Rebecca A Evans, et al.
Cell|January 24, 2012
EMT and dissemination precede pancreatic tumor formationAndrew D Rhim, Emily T Mirek, Nicole M Aiello, et al.
Cancer Cell|September 20, 2005
Pten constrains centroacinar cell expansion and malignant transformation in the pancreasBen Z Stanger, Bangyan Stiles, Gregory Y Lauwers, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Physiological reprogramming <i>in vivo</i> mediated by Sox4 pioneer factor activityTakeshi Katsuda, Jonathan Sussman, Kenji Ito, et al.
JCI Insight|June 24, 2024
N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearanceErin E Hollander, Rosemary E Flock, Jayne C McDevitt, et al.
Scientific Reports|January 31, 2026
Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancerJohn C McVey, Max M Wattenberg, Heather Coho, et al.
Cell Reports|March 12, 2014
De novo formation of insulin-producing "neo-β cell islets" from intestinal cryptsYi-Ju Chen, Stacy R Finkbeiner, Daniel Weinblatt, et al.
Journal of Oncology|August 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic CancerDongfeng Qu, Nathaniel Weygant, Jiannan Yao, et al.
Nature Communications|February 26, 2024
Cellular reprogramming in vivo initiated by SOX4 pioneer factor activityTakeshi Katsuda, Jonathan H Sussman, Kenji Ito, et al.
Scientific Reports|March 24, 2018
An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clustersNeha Bhagwat, Keely Dulmage, Charles H Pletcher, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Cancer Immunology Research|February 14, 2015
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic CarcinomaRafael Winograd, Katelyn T Byrne, Rebecca A Evans, et al.
Cell|January 24, 2012
EMT and dissemination precede pancreatic tumor formationAndrew D Rhim, Emily T Mirek, Nicole M Aiello, et al.
Cancer Cell|September 20, 2005
Pten constrains centroacinar cell expansion and malignant transformation in the pancreasBen Z Stanger, Bangyan Stiles, Gregory Y Lauwers, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Physiological reprogramming <i>in vivo</i> mediated by Sox4 pioneer factor activityTakeshi Katsuda, Jonathan Sussman, Kenji Ito, et al.
JCI Insight|June 24, 2024
N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearanceErin E Hollander, Rosemary E Flock, Jayne C McDevitt, et al.
Scientific Reports|January 31, 2026
Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancerJohn C McVey, Max M Wattenberg, Heather Coho, et al.
Cell Reports|March 12, 2014
De novo formation of insulin-producing "neo-β cell islets" from intestinal cryptsYi-Ju Chen, Stacy R Finkbeiner, Daniel Weinblatt, et al.
Journal of Oncology|August 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic CancerDongfeng Qu, Nathaniel Weygant, Jiannan Yao, et al.
Nature Communications|February 26, 2024
Cellular reprogramming in vivo initiated by SOX4 pioneer factor activityTakeshi Katsuda, Jonathan H Sussman, Kenji Ito, et al.
Scientific Reports|March 24, 2018
An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clustersNeha Bhagwat, Keely Dulmage, Charles H Pletcher, et al.
Pageof 19